GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
72 hedge funds and large institutions have $15.8M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
59% less capital invested
Capital invested by funds: $38.6M → $15.8M (-$22.8M)
Holders
72
Holding in Top 10
–
Calls
$585K
Puts
$82K
Top Buyers
| 1 | +$664K | |
| 2 | +$635K | |
| 3 | +$269K | |
| 4 |
Two Sigma Advisers
New York
|
+$193K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$192K |
Top Sellers
| 1 | -$6.33M | |
| 2 | -$3.03M | |
| 3 | -$375K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$357K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$314K |